JAMES M FRATES

CIK 1235598 · Chief Financial Officer · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.98M

Companies

3

Total Filings

210

Lifetime Open-Market Net

-$42.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMLX Chief Financial Officer 361,628 $14.59 $5.28M -$3.22M 23 2026-03-09
Sage Therapeutics, Inc. (SAGE) Delisted Director 1,810 $8.68 $15.7K -$4.48M 21 2025-07-31
ALKS SVP, Alks Inc; CFO ALKS 241,828 $44.28 $10.71M -$34.81M 166 2020-05-14

Recent Filings · Page 11 of 21

210 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-07-23 Sage Therapeutics, Inc. (SAGE) Delisted Buy (P) +5,000 $90.0K EDGAR
2014-07-16 ALKS Mixed -$303.6K EDGAR
2014-07-11 ALKS Mixed -$227.6K EDGAR
2014-03-21 ALKS Mixed -$241.8K EDGAR
2014-03-05 ALKS Mixed -$248.3K EDGAR
2014-01-17 ALKS Mixed -$245.7K EDGAR
2013-12-20 ALKS Exer (M) +8,130 $100.0K EDGAR
2013-12-18 ALKS Mixed −10,000 -$1.43M EDGAR
2013-12-13 ALKS Mixed -$189.8K EDGAR
2013-11-22 ALKS Sell (S) −4,988 -$189.0K EDGAR
Showing 101110 of 210
Page 11 of 21
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.